Explore which factors—audience relevance, content fit, and engagement quality—determine the best use of platforms like TikTok ...

In today’s ACT Brief, we look at how real-world data and AI are helping prevent costly study rescue, review the FDA’s ...

New 48-week results from Johnson & Johnson’s Phase IIIb APEX trial show Tremfya delivers durable symptom improvement, slows radiographic progression, and maintains a consistent safety profile in ...

ACT: At this year’s SCRS Summit, several site representatives raised concerns about overly complex protocols and patient ...

How sponsors can leverage technology to enhance, not hinder, site efficiency and usability Strategies to incorporate site ...

Data-driven planning aids in the design of feasible clinical trials from the outset, by simulating enrollment before the ...

In today’s ACT Brief, we look at how artificial intelligence is reshaping drug development decisions across pharma, discuss ...

In today’s ACT Brief, we examine declining site satisfaction and strategies to improve sponsor-site collaboration, review a ...

You have medical affairs being more involved on the research side, engaging with these HCPs to try to create referral ...

Gain insight into how principal investigator scarcity, frequent protocol amendments, and uneven site performance undermine ...

Understand how combining proprietary and real-world datasets with tokenization enables accurate protocol matching while ...

In contrast, by utilizing technology-driven tools more effectively, we can drive efficiencies, improve communication, and ...